Fertilysis

What Fertilysis does

Fertilysis is a Greece-based direct-to-consumer fertility diagnostics company focused on unexplained infertility and recurrent pregnancy loss. It sells a portfolio of at-home, self-collectable test kits spanning microbiome analysis (Female, Male, Vaginal, and Couples Microbiome), DNA Fragmentation Index analysis using flow cytometry with TUNEL assay, reproductive immunology panels (NK cell profiles, KIR-HLA-C mismatch, HLA-DQα matching, Th1/Th2 ratios, leukocyte antibody detection), and genetic and chromosomal screens (thrombophilia, karyotyping, FISH, telomere length). Samples are collected at home using non-invasive methods such as menstrual blood, vaginal swabs, and self-collected semen, then mailed to a central laboratory for analysis; results are returned by email with personalized treatment recommendations.

The company runs a dual model: a DTC e-commerce diagnostics business shipping kits worldwide, alongside a clinical practice located in Argyroupoli, Athens that delivers higher-margin treatment services including Lymphocyte Immunization Therapy (LIT), Endometrial PRP Therapy, diagnostic hysteroscopy, IVF/IUI programs, follicular monitoring, HyFosy, and OBGYN consultations. Per-kit pricing ranges from €320 to €1,950 for the Complete Panel, paid on a one-time basis, with a €190 OBGYN video consultation available as an add-on. Customer acquisition is primarily digital — content marketing, SEO, email, and social — supplemented by free written test-suggestion reports and free consultations as lead-conversion tools; a "Trip & Treat" offering ties international at-home testing to on-site treatment in Athens.

Fertilysis is incorporated as a Private Capital Company (IKE) under Greek law (FERTILYSIS IKE, VAT 801484769), privately owned and managed by founders Georgios Katsampekis and Panagiotis Venieratos, with no disclosed institutional investors, venture funding, or parent holding company, indicating a bootstrapped, founder-controlled capital structure. Headcount is reported at 1–10 employees, consistent with a lean operating model, and the company has no mobile app, no public API, no listed patents, and no disclosed certifications or regulatory clearances beyond its Greek corporate registration.

Name

Fertilysis

Legal name

FERTILYSIS

Website

https://fertilysis.com

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

Fertilysis is a Greece-based direct-to-consumer fertility diagnostics company that sells at-home, self-collectable test kits — covering microbiome, reproductive immunology, DNA fragmentation, and genetic screening — to couples with unexplained infertility and recurrent pregnancy loss worldwide, while also delivering clinical treatments at its Athens clinic.

Ownership category

akta.pro rank

Product category

Fertility Diagnostics and Reproductive Immunology

NAICS

Medical and Diagnostic Laboratories (62151), Medical and Diagnostic Laboratories (6215)

SIC

Services-Medical Laboratories (8071), Services-Specialty Outpatient Facilities, Nec (8093), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Fertility & Reproductive Endocrinology Telehealth (IVF/IUI, infertility evaluation) (HLALAHAA)

akta.pro secondary industries

Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening) (HLAAALAJ), Fertility, Reproductive Endocrinology & IVF Centers (HLAFAJAD)

Keywords

• Fertility diagnostics
• Reproductive immunology
• At-home fertility testing
• Unexplained infertility testing
• Recurrent miscarriage diagnostics

Headquarters

HQ city

Athens

HQ country

Greece

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

1. Diagnostic Testing Kits: One-time purchase of at-home fertility testing kits including Female Microbiome (690€), Male Microbiome (490€), Reproductive Immunology panels (520-1390€), Genetic Testing (320-590€), and Complete Panels (1950€). Samples self-collected at home and shipped to laboratory for analysis.
2. Medical Consultations: 45-minute video consultation with OBGYN specialists for second opinions, treatment planning, and prescription services priced at 190€.
3. Retesting Services: Discounted retesting services for post-treatment evaluation including Female Microbiome Retest (340€), Male Microbiome Retest (240€), and DNA Fragmentation Analysis Retest (320€).
4. Treatment Services: On-site fertility treatments including Lymphocyte Immunization Therapy (LIT), Endometrial PRP Therapy, Diagnostic Hysteroscopy, IVF/IUI Programs, and follicular monitoring at their Athens clinic.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Fertilysis provides mail-order, at-home fertility diagnostic test kits focused on unexplained infertility, recurrent pregnancy loss, and reproductive immunology, shipped worldwide without requiring a physician's referral. It complements these kits with in-clinic fertility services — including Lymphocyte Immunization Therapy (LIT), Endometrial PRP, diagnostic hysteroscopy, IVF, IUI, follicular monitoring, and OB/GYN consultations — delivered at its Athens facility.

Product overview

Fertilysis is a fertility diagnostics and treatment company specializing in unexplained infertility and recurrent miscarriages. The company operates a portfolio of at-home molecular diagnostic tests combined with clinical treatment services. The core testing products include microbiome analysis panels (Female Microbiome, Male Microbiome, Couples Microbiome, Vaginal Microbiome), DNA fragmentation testing (DFI), reproductive immunology testing (Autoimmunity, Alloimmunity, Full panels), and genetic/chromosomal screening (Thrombophilia, Karyotyping, FISH, Telomere Length). These are complemented by bundled offerings like the Complete Panel and Male Microbiome & DFI packages. On the treatment side, Fertilysis provides services including Lymphocyte Immunization Therapy (LIT), Endometrial PRP Therapy, Diagnostic Hysteroscopy, IVF/IUI Programs, Follicular Monitoring, HyFosy, and OBGYN consultations. All tests feature self-collectable, non-invasive sampling methods shipped worldwide, with results delivered via email.

Differentiator

Problem solved

Functional benefit

Products and services

• Female Microbiome Test At-home self-collectable test kit assessing the female reproductive microbiome profile for couples and women evaluating unexplained infertility or recurrent pregnancy loss.
• Male Microbiome Test At-home self-collectable test kit assessing the male reproductive microbiome profile, used alongside female testing or semen analysis to evaluate unexplained infertility.
• Couples Microbiome Test Combined male and female microbiome test kit designed for couples seeking a joint reproductive microbiome assessment.
• Vaginal Microbiome Test At-home self-collectable kit profiling the vaginal microbiome as part of reproductive health and infertility evaluation.
• DNA Fragmentation Index (DFI) Test At-home sperm DNA fragmentation test using TUNEL assay with flow cytometry to measure sperm DNA damage in men with infertility or recurrent miscarriage.
• Male Microbiome & DFI Bundle Combined bundle pairing the Male Microbiome Test with the DFI Test for a one-purchase male-factor fertility workup.
• Inflammation Index Test At-home test kit measuring reproductive-related inflammation markers relevant to infertility and recurrent pregnancy loss.
• Reproductive Full Test Comprehensive at-home fertility diagnostic panel combining multiple reproductive markers for couples seeking a broad unexplained-infertility workup.
• Reproductive Autoimmunity Test At-home panel testing autoimmune markers associated with recurrent pregnancy loss and reproductive failure.
• Reproductive Alloimmunity Test At-home panel testing alloimmune markers relevant to reproductive failure and recurrent miscarriage.
• Complete Panel All-in-one at-home fertility workup combining microbiome, immunology, DFI, inflammation, and genetic screening tests for unexplained infertility or recurrent miscarriage.
• Hereditary Thrombophilia Screening Genetic screening test for inherited thrombophilia mutations linked to recurrent pregnancy loss and reproductive complications.
• Peripheral Blood Karyotyping Cytogenetic test analyzing peripheral blood chromosomes for chromosomal abnormalities relevant to recurrent miscarriage and infertility.
• Semen FISH Chromosomal Analysis Semen-based fluorescence in situ hybridization (FISH) test detecting chromosomal abnormalities in sperm relevant to recurrent pregnancy loss and IVF failure.
• Telomere Length Test Test measuring telomere length as a reproductive and cellular aging marker associated with fertility outcomes.
• Lymphocyte Immunization Therapy (LIT) In-clinic reproductive immunology treatment for couples with alloimmune-related recurrent pregnancy loss, delivered at the Athens fertility clinic.
• Endometrial PRP Therapy In-clinic endometrial platelet-rich plasma therapy aimed at improving endometrial receptivity in patients with thin endometrium or implantation failure.
• Diagnostic Hysteroscopy In-clinic hysteroscopic procedure used to diagnose and treat intrauterine abnormalities contributing to infertility or recurrent pregnancy loss.
• IVF Program In-vitro fertilization treatment program delivered at the Athens fertility clinic, including cycle planning, monitoring, and embryo transfer.
• IUI Program Intrauterine insemination treatment program delivered at the Athens fertility clinic.
• Follicular / Ovarian Monitoring Ultrasound-based monitoring service tracking follicular development during natural or stimulated cycles for patients undergoing fertility treatment.
• HyFoSy (Hysterosalpingo-Contrast-Sonography) In-clinic sonography-based tubal patency assessment used as part of the fertility workup to evaluate fallopian tube openness.
• OBGYN Consultation Consultation with an obstetrician-gynecologist for fertility evaluation, treatment planning, or second opinions, delivered at the Athens clinic.
• Consultation & Prescription Remote or in-clinic consultation service providing personalized fertility-related prescriptions and treatment recommendations.

Quantifiable outcome

• Retesting recommended 1-2 months after treatment completion, and no later than 6 months from initial test
• +2 more outcomes

Segments5 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators1 record

Recent moves4 records

Expansion highlights4 records

Direct peers

• Proov: Sells at-home ovarian reserve and ovulation testing kits (e.g., PdG tests) directly online; comparable DTC fertility diagnostic model with self-collectable urine samples.
• Everlywell: DTC at-home diagnostics platform offering a broad menu of self-collected lab tests online; directly comparable mail-order testing, e-commerce distribution, and wellness-oriented consumer audience.
• Let's Get Checked: Global DTC at-home health testing company with self-collectable sample kits shipped internationally and clinician-backed results; comparable direct-to-consumer lab testing operating model.
• Genea Biomedx: Specialized IVF and fertility diagnostics developer (e.g., embryo culture, time-lapse, sperm DNA fragmentation assays); comparable fertility-focused diagnostic technology provider.
• Modern Fertility (Ro): DTC mail-order fertility hormone and ovarian reserve testing for women trying to conceive; directly comparable channel (own e-commerce storefront, at-home kit) and overlapping customer segment with Fertilysis.

Broad incumbents

• CooperSurgical: Large women's-health and fertility medical device/diagnostics company (PGT-A, sperm prep media, consumables for IVF labs); broader incumbent in the same clinical reproductive diagnostic space.
• Quest Diagnostics: Major U.S. clinical laboratory offering reproductive and genetic testing panels; comparable diagnostic lab capability and overlap with Fertilysis' genetic/karyotyping/FISH offerings.
• CCRM (now US Fertility): Large U.S. fertility clinic network offering IVF and advanced reproductive medicine services; comparable REI/IVF clinic service line alongside Fertilysis' Athens-based treatment suite.
• Shady Grove Fertility: Major U.S. fertility treatment provider with broad REI/IVF services including immunology-adjacent protocols; comparable specialty reproductive endocrinology clinic offering.
• Labcorp (Laboratory Corporation of America): Global clinical reference laboratory providing reproductive and genetic diagnostic testing services; comparable laboratory testing infrastructure and reproductive test menu, though B2B rather than DTC.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/fertilysis

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Fertilysis